On February 7, 2019 Replimune Group Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immunotherapies derived from its Immulytic platform, reported that Robert Coffin, Ph.D., Chief Executive Officer and Director of Replimune, will participate in fireside chats and host investor meetings at the following two conferences (Press release, Replimune, FEB 7, 2019, View Source [SID1234533119]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Guggenheim Healthcare Talks Forum – Oncology Day
Date: Thursday, February 14, 2019
Presentation Time: 1:30 pm ET
Location: St. Regis in New York, NY

8th Annual SVB Leerink Global Healthcare Conference
Date: Thursday, February 28, 2019
Presentation Time: 2:00 pm ET
Location: Lotte New York Palace in New York, NY